Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Decreased tissue stiffness in glioblastoma by MR Elastography is associated with increased cerebral blood flow

View ORCID ProfileSiri Fløgstad Svensson, View ORCID ProfileElies Fuster-Garcia, Anna Latysheva, Jorunn Fraser-Green, View ORCID ProfileWibeke Nordhøy, Omar Isam Darwish, View ORCID ProfileIvar Thokle Hovden, View ORCID ProfileSverre Holm, View ORCID ProfileEinar O. Vik-Mo, View ORCID ProfileRalph Sinkus, View ORCID ProfileKyrre Eeg Emblem
doi: https://doi.org/10.1101/2021.06.11.21258742
Siri Fløgstad Svensson
1Dept. of Diagnostic Physics, Oslo University Hospital, Oslo, Norway
2Department of Physics, University of Oslo, Oslo, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Siri Fløgstad Svensson
  • For correspondence: siriflo@uio.no
Elies Fuster-Garcia
1Dept. of Diagnostic Physics, Oslo University Hospital, Oslo, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Elies Fuster-Garcia
Anna Latysheva
3Department of Radiology, Oslo University Hospital, Oslo, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jorunn Fraser-Green
4The Intervention Centre, Oslo University Hospital, Oslo, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wibeke Nordhøy
1Dept. of Diagnostic Physics, Oslo University Hospital, Oslo, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Wibeke Nordhøy
Omar Isam Darwish
5Division of Imaging Sciences and Biomedical Engineering, King’s College, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ivar Thokle Hovden
1Dept. of Diagnostic Physics, Oslo University Hospital, Oslo, Norway
2Department of Physics, University of Oslo, Oslo, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ivar Thokle Hovden
Sverre Holm
2Department of Physics, University of Oslo, Oslo, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sverre Holm
Einar O. Vik-Mo
6Vilhelm Magnus Laboratory, Dept. of Neurosurgery, Oslo University Hospital, Oslo, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Einar O. Vik-Mo
Ralph Sinkus
5Division of Imaging Sciences and Biomedical Engineering, King’s College, London, United Kingdom
7INSERM U1148, LVTS, University Paris Diderot, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ralph Sinkus
Kyrre Eeg Emblem
1Dept. of Diagnostic Physics, Oslo University Hospital, Oslo, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Kyrre Eeg Emblem
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

PURPOSE Understanding how mechanical properties relate to functional changes in glioblastomas may help explain different treatment response between patients. The aim of this study was to map differences in biomechanical and functional properties between tumor and healthy tissue, to assess any relationship between them and to study their spatial distribution.

METHODS Ten patients with glioblastoma and 17 healthy subjects were scanned using MR Elastography, perfusion and diffusion MRI. Stiffness and viscosity measurements G′ and G′′, cerebral blood flow (CBF), apparent diffusion coefficient (ADC) and fractional anisotropy (FA) were measured in patients’ contrast-enhancing tumor, necrosis, edema, and gray and white matter, and in gray and white matter for healthy subjects. A regression analysis was used to predict CBF as a function of ADC, FA, G′ and G′′.

RESULTS Median G′ and G′′ in contrast-enhancing tumor were 13% and 37% lower than in normal-appearing white matter (P<0.01), and 8% and 6% lower in necrosis than in contrast-enhancing tumor, respectively (P<0.05). Tumors showed both inter-patient and intra-patient heterogeneity. Measurements approached values in normal-appearing tissue when moving outward from the tumor core, but abnormal tissue properties were still present in regions of normal-appearing tissue. Using both a linear and a random-forest model, prediction of CBF was improved by adding MRE measurements to the model (P<0.01).

CONCLUSIONS The inclusion of MRE measurements in statistical models helped predict perfusion, with stiffer tissue associated with lower perfusion values.

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

NCT03951142

Funding Statement

We gratefully acknowledge support from the European Union Horizon 2020 Programme: ERC Grant Agreement No. 758657-ImPRESS, Research and Innovation Grant Agreements No. 668039-FORCE and Marie Skłodowska-Curie grant agreement (No 844646-GLIOHAB), South-Eastern Norway Regional Health Authority (Grant Agreement No. 2017073 and 2013069), The Research Council of Norway FRIPRO (Grant Agreement No. 261984), the National Institute of Health R21 grant (Grant Agreement No. EB030757), and the German Research Foundation (DFG, SCHR 1542/1-1).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study was approved by the Norwegiean National Research Ethics Committee and the Oslo University Hospital review board.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Grant Support: We gratefully acknowledge support from the European Union’s Horizon 2020 Programme: ERC Grant Agreement No. 758657-ImPRESS, Research and Innovation Grant Agreements No. 668039-FORCE and Marie Skłodowska-Curie grant agreement (No 844646-GLIOHAB), South-Eastern Norway Regional Health Authority (Grant Agreement No. 2017073 and 2013069), The Research Council of Norway FRIPRO (Grant Agreement No. 261984), the National Institutes of Health R21 grant (Grant Agreement No. EB030757), and the German Research Foundation (DFG, SCHR 1542/1-1).

  • Conflict of interest: Nothing to disclose.

  • Declaration of interest: KEE: NordicNeuroLab AS, Bergen, Norway – Intellectual property rights.

Data Availability

All the data and the associated meta-data generated as a part of this study is publicly available by request through Zenodo (10.5281/zenodo.4926005).

https://zenodo.org/record/4926005

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted August 16, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Decreased tissue stiffness in glioblastoma by MR Elastography is associated with increased cerebral blood flow
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Decreased tissue stiffness in glioblastoma by MR Elastography is associated with increased cerebral blood flow
Siri Fløgstad Svensson, Elies Fuster-Garcia, Anna Latysheva, Jorunn Fraser-Green, Wibeke Nordhøy, Omar Isam Darwish, Ivar Thokle Hovden, Sverre Holm, Einar O. Vik-Mo, Ralph Sinkus, Kyrre Eeg Emblem
medRxiv 2021.06.11.21258742; doi: https://doi.org/10.1101/2021.06.11.21258742
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Decreased tissue stiffness in glioblastoma by MR Elastography is associated with increased cerebral blood flow
Siri Fløgstad Svensson, Elies Fuster-Garcia, Anna Latysheva, Jorunn Fraser-Green, Wibeke Nordhøy, Omar Isam Darwish, Ivar Thokle Hovden, Sverre Holm, Einar O. Vik-Mo, Ralph Sinkus, Kyrre Eeg Emblem
medRxiv 2021.06.11.21258742; doi: https://doi.org/10.1101/2021.06.11.21258742

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Radiology and Imaging
Subject Areas
All Articles
  • Addiction Medicine (216)
  • Allergy and Immunology (495)
  • Anesthesia (106)
  • Cardiovascular Medicine (1096)
  • Dentistry and Oral Medicine (196)
  • Dermatology (141)
  • Emergency Medicine (274)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (500)
  • Epidemiology (9767)
  • Forensic Medicine (5)
  • Gastroenterology (480)
  • Genetic and Genomic Medicine (2308)
  • Geriatric Medicine (222)
  • Health Economics (462)
  • Health Informatics (1559)
  • Health Policy (736)
  • Health Systems and Quality Improvement (603)
  • Hematology (236)
  • HIV/AIDS (503)
  • Infectious Diseases (except HIV/AIDS) (11641)
  • Intensive Care and Critical Care Medicine (617)
  • Medical Education (237)
  • Medical Ethics (67)
  • Nephrology (257)
  • Neurology (2142)
  • Nursing (134)
  • Nutrition (336)
  • Obstetrics and Gynecology (427)
  • Occupational and Environmental Health (517)
  • Oncology (1176)
  • Ophthalmology (364)
  • Orthopedics (128)
  • Otolaryngology (220)
  • Pain Medicine (146)
  • Palliative Medicine (50)
  • Pathology (311)
  • Pediatrics (695)
  • Pharmacology and Therapeutics (300)
  • Primary Care Research (267)
  • Psychiatry and Clinical Psychology (2180)
  • Public and Global Health (4657)
  • Radiology and Imaging (778)
  • Rehabilitation Medicine and Physical Therapy (457)
  • Respiratory Medicine (623)
  • Rheumatology (274)
  • Sexual and Reproductive Health (225)
  • Sports Medicine (210)
  • Surgery (251)
  • Toxicology (43)
  • Transplantation (120)
  • Urology (94)